Menu
Recruiting NCT07283653

Dissemination and Implementation of DIGEST™ as an Evidence-based Measurement Tool for Dysphagia: A Randomized Implementation Trial

No phase Interventional DIGEST Evidence Based Measurement Dysphagia Randomized Implementation

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: No intervention, DIGEST Training Program, DIGEST Training + Practice Facilitation.
Who it may be relevant to
Registry conditions: DIGEST, Evidence Based Measurement, Dysphagia, Randomized Implementation. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

To improve swallowing outcomes in cancer through clinical implementation of the Dynamic Imaging Grade of Swallowing Toxicity (DIGEST™) as an evidence-based practice (EBP) tool to grade pharyngeal dysphagia (difficulty swallowing) as a toxicity of cancer.

Detailed description

Primary Objective Assess the impact of implementation strategies on clinical adoption (reach) of DIGEST for oncology MBS studies.

Secondary Objective Assess the impact of implementation strategies on the fidelity (reliability) of DIGEST adoption for oncology MBS studies

Interventions

  • Other No intervention
    receive no active implementation
  • Other DIGEST Training Program
    Investigator led training program
  • Other DIGEST Training + Practice Facilitation
    Training plus practice facilitation

Primary outcome measures

  • Adoption of DIGEST in routine clinical documentation for oncology MBS studies [Time frame: Through study completion; an average of 1 year]

Eligibility criteria

Inclusion criteria

  • A hospital or clinic affiliated with the Veteran's Affairs system, University of Wisconsin system, or Ohio State University system.
  • A minimum average of 10 Modified Barium Swallow (MBS) procedures per month in oncology patients in preceding year.
  • MBS imaging files are recorded and archived as a routine procedure (and accessible to researchers).

Exclusion criteria

N/A

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Diagnostic

Study locations

United States · 1 center
  • MD Anderson Cancer Center — Houston

Identifiers

NCT: NCT07283653 · 2024-1270

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗